相关实验视频
Updated: Jul 23, 2025

09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
15.4K
一个功能失调的miR-1-TRPS1-MYOG轴通过抑制终端肌原分化来驱动ERMS
Sören S Hüttner1, Henriette Henze1, Dana Elster1
1Leibniz Institute on Aging - Fritz Lipmann Institute, Beutenbergstrasse 11, 07745 Jena, Germany.
概括
转录抑制剂TRPS1在胚胎狂宫肌肉瘤中高度表达,阻碍肌肉细胞的分化. 降低TRPS1水平可以促进肌原分化,并作为这种儿科癌症的潜在治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 发展生物学 发展生物学
背景情况:
- 轮骨髓瘤是一种常见的儿科软组织瘤,有两个主要亚型:胚胎 (PAX3/7-FOXO1融合负) 和气囊 (PAX3/7-FOXO1融合阳性).
- TRPS1是一种转录抑制剂,通过调节肌肉发生过程中的基因表达,在正常肌肉发育中发挥作用.
研究的目的:
- 为了研究TRPS1表达在胚胎狂宫肌肉瘤 (eRMS) 发病过程中的作用.
- 探索针对TRPS1进行eRMS治疗的治疗潜力.
主要方法:
- 在eRMS亚型中分析TRPS1表达水平.
- 在体外和体内研究涉及TRPS1操纵在拉布多米索尔科马细胞.
- 研究微RNA-1 (miR-1) 对TRPS1的调节及其与MYOD1.1的相互作用.
- 评估TRPS1对肌原蛋白 (MYOG) 促进剂活性的影响.
主要成果:
- 在Rhabdomyosarcoma的胚胎亚型中,TRPS1的表达显著升高.
- 过度表达TRPS1抑制了终端肌原分化,而其减少则促进了eRMS细胞的分化.
- TRPS1的水平由miR-1调节,TRPS1与MYOD1共享基因组结合点,这是一个关键的肌肉调节因子.
- TRPS1直接抑制MYOG表达,这是肌细胞分化的一个关键步骤.
结论:
- 增加TRPS1表达会损害胚胎性狂宫肌肉瘤中的肌原分化.
- 降低TRPS1水平提供了一种潜在的治疗策略,以诱导eRMS的终端肌原分化.
- 向TRPS1可能会导致后转移性髓管的产生,为eRMS提供一种新的治疗方法.
相关概念视频
Formation of Muscle Fibers from Myoblasts
5.0K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.0K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
The Unfolded Protein Response
4.8K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Regulation of the Unfolded Protein Response
2.5K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K

